Shares of HemaCare Co. (OTCMKTS:HEMA – Get Free Report) shot up 0.6% on Thursday. The stock traded as high as $25.31 and last traded at $25.31. 5,400 shares were traded during trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Trading Up 0.6%
The firm has a 50-day moving average of $25.31 and a 200-day moving average of $25.31.
HemaCare Company Profile
HemaCare Corporation was a biotechnology company that supplied high-quality human biological materials for research and drug development. Its products included whole blood, plasma, serum, peripheral blood mononuclear cells (PBMCs), leukopaks, bone marrow, cord blood and other human cell-based specimens.
The company supported pharmaceutical and biotechnology companies, academic institutions and research organizations working in areas such as immunology, cell therapy, cancer research and infectious disease.
Further Reading
- Five stocks we like better than HemaCare
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
